Home / Inspections / 1004043

FDA Inspection 1004043 — Faramarz Ismail-Beigi, MD

Faramarz Ismail-Beigi, MD — FEI 3013307135

The FDA completed an inspection of Faramarz Ismail-Beigi, MD on Mar 10, 2017 in Cleveland, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 10, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cleveland, OH (United States)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.